Gordian Capital Singapore Pte Ltd Sells 1,170 Shares of McKesson Corporation $MCK

Key Points

• Gordian Capital Singapore cut its stake in McKesson by 85.4%, selling 1,170 shares and ending the quarter with 200 shares worth about $155,000.
• Analysts remain broadly positive with a consensus rating of "Moderate Buy" (13 Buys, 4 Holds) and an average target of $960.93, while firms like Barclays and Leerink have raised targets to $1,050 and $1,085 respectively.
• McKesson beat quarterly expectations with $9.34 EPS (vs. $9.19 est.) and $106.16B revenue, set FY2026 guidance of $38.80–$39.20 EPS, and announced a $0.82 quarterly dividend (0.4% yield).

Gordian Capital Singapore Pte Ltd lessened its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 85.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200 shares of the company's stock after selling 1,170 shares during the period. Gordian Capital Singapore Pte Ltd's holdings in McKesson were worth $155,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of McKesson by 2.0% in the second quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company's stock valued at $8,846,186,000 after buying an additional 232,286 shares during the period. Geode Capital Management LLC lifted its position in McKesson by 4.1% in the 2nd quarter. Geode Capital Management LLC now owns 2,820,724 shares of the company's stock valued at $2,057,065,000 after acquiring an additional 112,224 shares in the last quarter. Franklin Resources Inc. boosted its stake in McKesson by 3.5% in the 3rd quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock worth $2,071,428,000 after purchasing an additional 90,948 shares during the period. Alliancebernstein L.P. boosted its stake in McKesson by 150.4% in the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company's stock worth $1,661,956,000 after purchasing an additional 1,362,386 shares during the period. Finally, Norges Bank bought a new position in McKesson during the 2nd quarter worth about $1,346,661,000. 85.07% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on MCK. Barclays upped their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 18th. Morgan Stanley reaffirmed an "overweight" rating and set a $966.00 price target on shares of McKesson in a research report on Thursday, January 29th. Leerink Partners reiterated an "outperform" rating and issued a $1,085.00 price objective on shares of McKesson in a report on Thursday, March 5th. Zacks Research cut shares of McKesson from a "strong-buy" rating to a "hold" rating in a report on Tuesday, November 25th. Finally, Raymond James Financial set a $970.00 price target on shares of McKesson in a research report on Thursday, March 5th. Thirteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, McKesson currently has a consensus rating of "Moderate Buy" and an average target price of $960.93.

McKesson Trading Down 1.4%

Shares of MCK opened at $928.60 on Wednesday. The company's fifty day simple moving average is $886.79 and its 200 day simple moving average is $820.88. McKesson Corporation has a 1-year low of $635.00 and a 1-year high of $999.00. The company has a market cap of $113.74 billion, a price-to-earnings ratio of 26.71, a PEG ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson's dividend payout ratio is currently 9.43%.

Insider Activity at McKesson

In other McKesson news, Director Maria Martinez sold 349 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the transaction, the director directly owned 301 shares in the company, valued at $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the firm's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president owned 2,989 shares of the company's stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 3,868 shares of company stock worth $3,743,820 in the last three months. 0.08% of the stock is owned by company insiders.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.